Gene Therapies Pave the Way to a Potential Cure for Sickle Cell Disease

Stay on top of the latest US health policy and global health technology assessment news

Health Policy Weekly

Health Policy Weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care. Developed by a multidisciplinary editorial board that includes Xcenda’s health policy and reimbursement strategy specialists, Health Policy Weekly is delivered to your inbox every Friday.

HTA Quarterly

From at-a-glance updates on important HTA decisions, to reviews that shine a spotlight on what those decisions mean for specific therapeutic areas, each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs; as well as Xcenda’s unique perspective so you are more prepared to address the challenges of an uncertain and rapidly changing healthcare environment.

Start a conversation

We’re value drivers and problem solvers. Let us connect you with experts who understand your world and what success demands.
Three people in a discussion